These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8849381)

  • 21. Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism. The Coagulation Project Investigators of the Bolus Alteplase Pulmonary Embolism Group.
    Agnelli G; Iorio A; Parise P; Goldhaber SZ; Levine MN
    Blood Coagul Fibrinolysis; 1997 Jun; 8(4):216-22. PubMed ID: 9199818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnostic value of hemostasis activation markers in acute deep vein thrombosis].
    Tajanko E; Galar M; Piszcz J; Kłoczko J
    Pol Arch Med Wewn; 2002 Mar; 107(3):237-41. PubMed ID: 12107982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on coagulation-fibrinolytic system in diabetic nephropathy--with reference to plasma TAT and alpha 2PIC].
    Watanabe S; Ogihara T; Iyori S; Kaneshige H; Nomoto Y; Sakai H
    Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):995-9. PubMed ID: 2148199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of blood coagulation and fibrinolysis in diabetes mellitus: evaluation by plasma levels of thrombin-antithrombin III complex and plasmin-alpha 2-plasmin inhibitor complex.
    Takahashi H; Tsuda A; Tatewaki W; Wada K; Niwano H; Shibata A
    Thromb Res; 1989 Sep; 55(6):727-35. PubMed ID: 2528845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombin-antithrombin complex and alpha2-plasmin inhibitor-plasmin complex levels after cesarean section in normal pregnancies and pre-eclampsia.
    Hayashi M; Hamada Y; Ohkura T
    Int J Gynaecol Obstet; 2003 Aug; 82(2):213-6. PubMed ID: 12873784
    [No Abstract]   [Full Text] [Related]  

  • 26. Blood coagulation and fibrinolysis in eclamptic patients and their correlation with the clinical signs.
    Halim A; Bhuiyan AB; Azim FA; Khatun S; Kanayama N; el Maradny E; Maehara K; Hiroshi K; Terao T
    Gynecol Obstet Invest; 1995; 39(2):97-102. PubMed ID: 7772198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of hemostatic markers and thrombomodulin in systemic lupus erythematosus: evidence for a prothrombotic state.
    Kiraz S; Ertenli I; Benekli M; Haznedaroğlu IC; Calgüneri M; Celik I; Apraş S; Kirazli S
    Lupus; 1999; 8(9):737-41. PubMed ID: 10602446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state.
    Pereira J; Alfaro G; Goycoolea M; Quiroga T; Ocqueteau M; Massardo L; Pérez C; Sáez C; Panes O; Matus V; Mezzano D
    Thromb Haemost; 2006 Jan; 95(1):94-9. PubMed ID: 16543967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes in coagulation and fibrinolysis cascades upon extracorporeal circulation].
    Kanamori N; Koiwa F; Uda S
    Nihon Rinsho; 1991 Dec; 49 Suppl():81-6. PubMed ID: 1839690
    [No Abstract]   [Full Text] [Related]  

  • 30. The clinical significance of TAT, PIC, TM, and t-PAIC in vascular events of BCR/ABL-negative myeloproliferative neoplasms.
    Huang K; Mo Q; Liao C; Feng S; Liu G; Jiang D; Lei P
    Clin Exp Med; 2024 May; 24(1):107. PubMed ID: 38776019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Plasma levels of antithrombin III, thrombin-antithrombin III complex, alpha 2 plasmin inhibitor and plasmin alpha 2 plasmin inhibitor complex in normal and sick newborn infants].
    Shiiki M; Ariyoshi N; Nakamura T; Shirahata A
    Rinsho Ketsueki; 1991 Jul; 32(7):758-65. PubMed ID: 1833569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of enzyme-linked immunosorbent assay to measure thrombin-antithrombin III complexes in horses with colic.
    Topper MJ; Prasse KW
    Am J Vet Res; 1996 Apr; 57(4):456-62. PubMed ID: 8712506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.
    Kario K; Matsuo T
    Atherosclerosis; 1993 Nov; 103(2):131-8. PubMed ID: 8292090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations of haemostatic markers in various subtypes and phases of stroke.
    Yamazaki M; Uchiyama S; Maruyama S
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):707-12. PubMed ID: 7507362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
    Kaibara M; Watanabe T; Ooka F; Liang SG; Aisaka K; Okinaga S
    Clin Hemorheol Microcirc; 2001; 24(2):93-9. PubMed ID: 11381184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coagulation and fibrinolysis in patients with chronic renal failure undergoing conservative treatment.
    Tomura S; Nakamura Y; Deguchi F; Ando R; Chida Y; Marumo F
    Thromb Res; 1991 Oct; 64(1):81-90. PubMed ID: 1776141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation.
    Tóth NK; Csanádi Z; Hajas O; Kiss A; Nagy-Baló E; Kovács KB; Sarkady F; Muszbek L; Bereczky Z; Csiba L; Bagoly Z
    Biomed Res Int; 2017; 2017():3678017. PubMed ID: 28713823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental haemorrhage and blood component transfusion in humans: no change in plasma concentration of thrombin-antithrombin complex and plasmin-antiplasmin complex.
    Henriksson AE; Nilsson TK; Jansson U; Bergqvist D
    Thromb Res; 1996 Jun; 82(5):409-15. PubMed ID: 8771701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of coagulation and fibrinolysis during surgery, analyzed by molecular markers.
    Kambayashi J; Sakon M; Yokota M; Shiba E; Kawasaki T; Mori T
    Thromb Res; 1990 Oct; 60(2):157-67. PubMed ID: 2149215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Concentration of thrombin antithrombin III complex and plasmin alpha 2-plasmin inhibitor complex in nephrotic syndrome].
    Kobayashi M; Katayama T; Ochiai S; Yoshida M; Kaito K; Masuoka H; Shimada T; Nishiwaki K; Sakai O
    Nihon Jinzo Gakkai Shi; 1991 Jul; 33(7):653-8. PubMed ID: 1836241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.